These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 30431206)
21. A risk signature of four aging-related genes has clinical prognostic value and is associated with a tumor immune microenvironment in glioma. Luo H; Tao C; Long X; Huang K; Zhu X Aging (Albany NY); 2021 Jun; 13(12):16198-16218. PubMed ID: 34114970 [TBL] [Abstract][Full Text] [Related]
22. Prognostic power of a lipid metabolism gene panel for diffuse gliomas. Wu F; Zhao Z; Chai RC; Liu YQ; Li GZ; Jiang HY; Jiang T J Cell Mol Med; 2019 Nov; 23(11):7741-7748. PubMed ID: 31475440 [TBL] [Abstract][Full Text] [Related]
23. A four-protein expression prognostic signature predicts clinical outcome of lower-grade glioma. Patil V; Mahalingam K Gene; 2018 Dec; 679():57-64. PubMed ID: 30077762 [TBL] [Abstract][Full Text] [Related]
24. Identification of potential biomarkers related to glioma survival by gene expression profile analysis. Hsu JB; Chang TH; Lee GA; Lee TY; Chen CY BMC Med Genomics; 2019 Mar; 11(Suppl 7):34. PubMed ID: 30894197 [TBL] [Abstract][Full Text] [Related]
25. Prognostic value of a nine-gene signature in glioma patients based on tumor-associated macrophages expression profiling. Shan X; Zhang C; Wang Z; Wang K; Wang J; Qiu X; Jiang T; Yang P Clin Immunol; 2020 Jul; 216():108430. PubMed ID: 32325251 [TBL] [Abstract][Full Text] [Related]
26. Prognostic value and their clinical implication of 89-gene signature in glioma. Shahid M; Cho KM; Nguyen MN; Choi TG; Jo YH; Aryal SN; Yoo JY; Yun HR; Lee JW; Eun YG; Lee JS; Kang I; Ha J; Yoon HJ; Kim SY; Kim SS Oncotarget; 2016 Aug; 7(32):51237-51250. PubMed ID: 27323413 [TBL] [Abstract][Full Text] [Related]
27. Identification of a Prognostic Hypoxia-Associated Gene Set in IDH-Mutant Glioma. Dao Trong P; Rösch S; Mairbäurl H; Pusch S; Unterberg A; Herold-Mende C; Warta R Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30257451 [TBL] [Abstract][Full Text] [Related]
28. Identification and validation of an autophagy-related signature for predicting survival in lower-grade glioma. Feng S; Liu H; Dong X; Du P; Guo H; Pang Q Bioengineered; 2021 Dec; 12(2):9692-9708. PubMed ID: 34696669 [TBL] [Abstract][Full Text] [Related]
30. Comprehensive analysis of genes based on chr1p/19q co-deletion reveals a robust 4-gene prognostic signature for lower grade glioma. Zhang C; Yu R; Li Z; Song H; Zang D; Deng M; Fan Y; Liu Y; Zhang Y; Qu X Cancer Manag Res; 2019; 11():4971-4984. PubMed ID: 31213913 [No Abstract] [Full Text] [Related]
31. A radiosensitivity gene signature in predicting glioma prognostic via EMT pathway. Meng J; Li P; Zhang Q; Yang Z; Fu S Oncotarget; 2014 Jul; 5(13):4683-93. PubMed ID: 24970813 [TBL] [Abstract][Full Text] [Related]
32. An immune-related lncRNA signature for patients with anaplastic gliomas. Wang W; Zhao Z; Yang F; Wang H; Wu F; Liang T; Yan X; Li J; Lan Q; Wang J; Zhao J J Neurooncol; 2018 Jan; 136(2):263-271. PubMed ID: 29170907 [TBL] [Abstract][Full Text] [Related]
33. A prognostic signature of five pseudogenes for predicting lower-grade gliomas. Liu B; Liu J; Liu K; Huang H; Li Y; Hu X; Wang K; Cao H; Cheng Q Biomed Pharmacother; 2019 Sep; 117():109116. PubMed ID: 31247469 [TBL] [Abstract][Full Text] [Related]
34. Metabolic expression profiling stratifies diffuse lower-grade glioma into three distinct tumour subtypes. Wu F; Liu YW; Li GZ; Zhai Y; Feng YM; Ma WP; Zhao Z; Zhang W Br J Cancer; 2021 Jul; 125(2):255-264. PubMed ID: 34006924 [TBL] [Abstract][Full Text] [Related]
35. N6-methyladenine-related genes affect biological behavior and the prognosis of glioma. Qu S; Chen Z; Liu B; Liu J; Wang H Cancer Med; 2021 Jan; 10(1):98-108. PubMed ID: 33264518 [TBL] [Abstract][Full Text] [Related]
36. Identification of an Inflammatory Response-Related Gene Signature to Predict Survival and Immune Status in Glioma Patients. Yan Z; Gao Y; Yu J; Shen Z; Bu X J Immunol Res; 2022; 2022():8972730. PubMed ID: 35647198 [TBL] [Abstract][Full Text] [Related]
37. Prognostic value of a microRNA signature as a novel biomarker in patients with lower-grade gliomas. Qian Z; Li Y; Fan X; Zhang C; Wang Y; Jiang T; Liu X J Neurooncol; 2018 Mar; 137(1):127-137. PubMed ID: 29204839 [TBL] [Abstract][Full Text] [Related]
38. Identification of a five B cell-associated gene prognostic and predictive signature for advanced glioma patients harboring immunosuppressive subtype preference. Zhang C; Li J; Wang H; Song SW Oncotarget; 2016 Nov; 7(45):73971-73983. PubMed ID: 27738332 [TBL] [Abstract][Full Text] [Related]
39. An NF-κB signature predicts low-grade glioma prognosis: a precision medicine approach based on patient-derived stem cells. Ius T; Ciani Y; Ruaro ME; Isola M; Sorrentino M; Bulfoni M; Candotti V; Correcig C; Bourkoula E; Manini I; Pegolo E; Mangoni D; Marzinotto S; Radovic S; Toffoletto B; Caponnetto F; Zanello A; Mariuzzi L; Di Loreto C; Beltrami AP; Piazza S; Skrap M; Cesselli D Neuro Oncol; 2018 May; 20(6):776-787. PubMed ID: 29228370 [TBL] [Abstract][Full Text] [Related]
40. Identification of an energy metabolism-related signature associated with clinical prognosis in diffuse glioma. Zhou Z; Huang R; Chai R; Zhou X; Hu Z; Wang W; Chen B; Deng L; Liu Y; Wu F Aging (Albany NY); 2018 Nov; 10(11):3185-3209. PubMed ID: 30407923 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]